---
pmid: '30232230'
title: The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.
authors:
- Csukasi F
- Duran I
- Barad M
- Barta T
- Gudernova I
- Trantirek L
- Martin JH
- Kuo CY
- Woods J
- Lee H
- Cohn DH
- Krejci P
- Krakow D
journal: Sci Transl Med
year: '2018'
full_text_available: false
pmcid: PMC7529349
doi: 10.1126/scitranslmed.aat9356
---

# The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.
**Authors:** Csukasi F, Duran I, Barad M, Barta T, Gudernova I, Trantirek L, Martin JH, Kuo CY, Woods J, Lee H, Cohn DH, Krejci P, Krakow D
**Journal:** Sci Transl Med (2018)
**DOI:** [10.1126/scitranslmed.aat9356](https://doi.org/10.1126/scitranslmed.aat9356)
**PMC:** [PMC7529349](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529349/)

## Abstract

1. Sci Transl Med. 2018 Sep 19;10(459):eaat9356. doi:
10.1126/scitranslmed.aat9356.

The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR 
signaling.

Csukasi F(1), Duran I(1), Barad M(1), Barta T(2), Gudernova I(3), Trantirek 
L(4), Martin JH(1), Kuo CY(5), Woods J(5), Lee H(6), Cohn DH(1)(7)(8), Krejci 
P(1)(3)(9)(10), Krakow D(11)(7)(12)(13).

Author information:
(1)Department of Orthopaedic Surgery, University of California-Los Angeles, Los 
Angeles, CA 90095, USA.
(2)Department of Histology and Embryology, Faculty of Medicine, Masaryk 
University, 62500 Brno, Czech Republic.
(3)Department of Biology, Faculty of Medicine, Masaryk University, 62500 Brno, 
Czech Republic.
(4)Central European Institute of Technology, Masaryk University, 62500 Brno, 
Czech Republic.
(5)Department of Pediatrics, University of California-Los Angeles, Los Angeles, 
CA 90095, USA.
(6)Department of Pathology and Laboratory Medicine, University of California-Los 
Angeles, Los Angeles, CA 90095, USA.
(7)Orthopaedic Institute for Children, University of California-Los Angeles, Los 
Angeles, CA 90095, USA.
(8)Department of Molecular, Cell and Developmental Biology, University of 
California-Los Angeles, Los Angeles, CA 90095, USA.
(9)International Clinical Research Center, St. Anne's University Hospital, 65691 
Brno, Czech Republic.
(10)Institute of Animal Physiology and Genetics of the Czech Academy of 
Sciences, 60200 Brno, Czech Republic.
(11)Department of Orthopaedic Surgery, University of California-Los Angeles, Los 
Angeles, CA 90095, USA. dkrakow@mednet.ucla.edu.
(12)Department of Human Genetics, University of California-Los Angeles, Los 
Angeles, CA 90095, USA.
(13)Department of Obstetrics and Gynecology, University of California-Los 
Angeles, Los Angeles, CA 90095, USA.

Studies have suggested a role for the mammalian (or mechanistic) target of 
rapamycin (mTOR) in skeletal development and homeostasis, yet there is no 
evidence connecting mTOR with the key signaling pathways that regulate 
skeletogenesis. We identified a parathyroid hormone (PTH)/PTH-related peptide 
(PTHrP)-salt-inducible kinase 3 (SIK3)-mTOR signaling cascade essential for 
skeletogenesis. While investigating a new skeletal dysplasia caused by a 
homozygous mutation in the catalytic domain of SIK3, we observed decreased 
activity of mTOR complex 1 (mTORC1) and mTORC2 due to accumulation of DEPTOR, a 
negative regulator of both mTOR complexes. This SIK3 syndrome shared skeletal 
features with Jansen metaphyseal chondrodysplasia (JMC), a disorder caused by 
constitutive activation of the PTH/PTHrP receptor. JMC-derived chondrocytes 
showed reduced SIK3 activity, elevated DEPTOR, and decreased mTORC1 and mTORC2 
activity, indicating a common mechanism of disease. The data demonstrate that 
SIK3 is an essential positive regulator of mTOR signaling that functions by 
triggering DEPTOR degradation in response to PTH/PTHrP signaling during 
skeletogenesis.

Copyright Â© 2018 The Authors, some rights reserved; exclusive licensee American 
Association for the Advancement of Science. No claim to original U.S. Government 
Works.

DOI: 10.1126/scitranslmed.aat9356
PMCID: PMC7529349
PMID: 30232230 [Indexed for MEDLINE]

Conflict of interest statement: Competing interests: The authors declare that 
they have no competing interests.
